When female mammals compensate for sex differences in the dosage of X linked genes by inactivating X chromosomes, the X chromosome(s) that is silenced has a major role in the process. In all mammals, a non-coding RNA, encoded by the X, is essential to its being inactivated by epigenetic factors ([@B9]). Clearly, the bi-directional spread of Xist RNA from its locus in the middle of the X chromosome initiates the inactivation process in eutherian mammals ([@B2]; [@B3]). In addition, the other long non coding RNAs, implicated in the process, i.e., the potential *Xist* repressors, rodent-specific *Tsix* ([@B16]), and the primate specific *XACT* ([@B38]), are also encoded by the X chromosome. Once coated with enough Xist RNA, the future inactive X moves toward the nuclear lamina, where its chromatin is transformed from euchromatin to heterochromatin ([@B21]; [@B27]).

The silencing of the future inactive X, or Xs, is attributable to a Rube-Goldberg type of mechanism that not only brings it close to the nuclear periphery (where inactive chromatin tends to reside), but also attracts the epigenetic factors that silence it. Ultimately, the binding of Xist RNA results in expulsion of factors from the inactive X that make chromatin accessible for transcription ([@B14]). The few active (escape) genes on that X chromosome manage to find their way out of the heterochromatic mass of inactive chromatin towards the center of the nucleus, where transcription occurs ([@B7]). Yet, Xist RNA cannot do this alone, as autosomal gene products are essential to complete the silencing process ([@B21]; [@B27]; [@B30]).

In pursuit of autosomal genes that cooperate with the X chromosome, [@B31] used ENU chemical mutagenesis to screen for autosomal mutations involved in the initiation of X inactivation in mice. They identified regions of mouse chromosomes 5, 10, and 15, which seemed to affect the choice of the mouse inactive X. More recent studies in mice have elucidated the essential autosomal products that interact with Xist RNA to silence the chromosome ([@B21]; [@B4]; [@B27]; [@B36]) ([Table 1](#T1){ref-type="table"}). These include the lamin B receptor (*Lbr)*, the satellite attachment factor A (*Saf-A*) and *Sharp* (*Smrt* and Hdac Associated Repressor Protein, also called *Spen*). *SPEN*, *LBR*, and *SAFA* map to human chromosome 1; *Lbr* and *Safa* also map to mouse chromosome 1, whereas *Sharp* is on mouse chromosome 4 (orthologous to human chromosome 1). Other genes that have been implicated in the silencing process are *RBM 15* and *SETDB1*, on human chromosome 1, and mouse chromosome 3 -- also orthologous to human chromosome 1. Therefore, the genes on human chromosome 1 that play a role in silencing the future inactive X also map to mouse chromosome 1 or its orthologs ([Table 1](#T1){ref-type="table"} and [Figure 1A](#F1){ref-type="fig"}). Conceivably, genes that were on three different chromosomes in mice have evolved to be on a single human chromosome to facilitate their interaction in silencing the X.

###### 

Location of mouse and human genes that silence the inactive X.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Human GENE**   **Human CHROMOSOME**   **5′ location of Human Gene (*GRch38*)**   **Mouse GENE**       **5′ location of Mouse Gene (*GRCm38*)**   **Citation for Mouse Genes**
  ---------------- ---------------------- ------------------------------------------ -------------------- ------------------------------------------ ----------------------------------
  SPEN             ***1p36.21***          ***1:15,847,863*^∗^**                      Sharp^∗∗^ (Spen)     ***4:141,467,890***                        [@B21]

  RBM15            ***1p13.3***           ***1:110,338,928***                        Rbm15                ***3:107,325,421***                        *McHugh- MoindrotPatil* ([@B30])

  LBR              ***1q42.12***          ***1:225,401,501***                        Lbr                  ***1:181,815,315***                        *McHugh Chen* ([@B4])

  HNRNPC           14q11.2                14:21,209,135                              Hnrnpc               14:52,073,380                              *McHugh*

  RALYL            8q21.2                 8:84,182,764                               Raly\                ***3:13,471,655*** 2:154,791,096           *McHugh*
                                                                                     Ralyl                                                           

  HNRNPM           19p13.2                19:8,444,574                               Hnrnpm               17:33646233                                *McHugh*

  HDAC3            5q13.3                 5:141,620,875                              Hdac3                18:37936971                                *McHugh*

  HNRNPU (SAFA)    ***1q44***             ***1:244,850,299***                        Hnrnpu or Safa       ***1:178321108***                          *McHugh*

  CELF1            11p11.2                11:47,465,932                              Celf1                2: 90940387                                *Moindrot*

  PTBP1            19p13.3                19:797,391                                 Ptbp1                10:79854432                                *McHugh*

  Not found                                                                          Myef2                2:125,084,628                              *Moindrot*

  NCOR1            17p12-p11              17:16,030,093                              NCoR-Hdac3 complex   11:62316426                                *Moindrot*

  CIZ1             9q34.11                9:128,166,064                              Ciz1                 2: 32363005                                *Moindrot Sunwoo* ([@B36])

  SETDB1           ***1q21.3***           ***1:150,926,245***                        Setdb1               ***3:95323525***                           *Moindrot*

  WTAP             6q25.3                 6:159,726,695                              Wtap                 17: 12966799                               *Moindrot*

  HDAC1            ***1p35.2-p35.1***     ***1:32,292,102***                         Hdac1                ***4:129,516,104***                        *This paper*
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

∗

Bold italics: Human chromosome 1 or mouse orthologs of human chromosome 1.

∗∗

SPEN(SMART/HDAC1 associated repressor protein = SHARP.

![**(A)** Human chromosome 1 with relevant genes, bent to show telomeres in proximity: SPEN 1p36.2, HDAC1 1p35.2, RBM15 1p13.3, LBR 1q42.12, and SAFA 1q44 (see [Table 1](#T1){ref-type="table"}). **(B)** Human chromosome 19 insert with relevant genes, showing proximity of genes in 19p13.1-13.2: UHRF1, SAFB2, SAFB, ZNF 358, ZNF 699, DNMT1, ZNF 823, and ZNF 69 (see [Table 2](#T2){ref-type="table"}).](fcell-07-00144-g001){#F1}

In prokaryotes, interactions between genes with a common function are facilitated because such genes are contiguous in the genome, organized into operons, with a common promoter ([@B13]). On the other hand, most eukaryotic genes that interact with each other, do not share promotors, and are less well clustered ([@B6]). Yet, it has become apparent that the spatial arrangement of genes in the mammalian nucleus is non-random; chromosome folding and intermingling enable the proximity of genes that reside on the same chromosome, by looping, and even on different chromosomes, by chromosome clustering. The likely advantage of interactions between genes is coordination of their expression -- perhaps in the same transcription factory, thought to occur in a discrete nuclear region ([@B33]).

Based on HI-C studies of the human genome ([@B17]), [@B37] showed that a significant number of functional groups (pairs of interacting proteins, genes with common functions and those in interactive pathways) are either clustered within the same chromosome or dispersed over a relatively few chromosomes. Those on different chromosomes tend to co-localize in space. These investigators found that, genes, which function together, tend to reside on fewer chromosomes than expected by chance. On the same chromosome, they are closer to each other than randomly chosen genes; on different chromosomes, they tend to be closer to each other in 3D space ([@B37]). Among the best documented inter-chromosomal interactions are those between the mouse X chromosomal gene, *Xist*, and the autosomal epigenetic factors mentioned above, that help silence the X chromosome from which the up-regulated *Xist* locus is being transcribed ([@B6]).

When extending her observations in mice to other mammals, Lyon suggested there was only a single *active* X, no matter the number of X's in a cell ([@B19]); however, the literature has persisted in labeling the mammalian process of X dosage compensation, X inactivation, which focuses us on the process of silencing the inactive X. Therefore, the salient question has been, "How does one *choose* the X chromosome that becomes *inactive*?" Because Xist RNA is able to silence any chromosome into which it is inserted ([@B15]; [@B26]), it is surprising that few ask the pertinent question, "What protects the single active X from silencing by its own *Xist* locus?" ([@B23]; [@B24]).

Further, it has not been easy to show how the mouse *inactive* X is chosen. Earlier studies suggested that an infrequent physical association (kissing) between the *Xist* loci of the two X chromosomes in mouse embryos determined the choice of inactive X ([@B39]; [@B1]), but more recent studies indicate that neither the expression of *Xist* nor *Tsix*, its antisense RNA, is affected by the interaction ([@B5]; [@B32]).

In addition, [@B12] and [@B11] recently showed that in mice, the choice of *active* X is determined prenatally. Having been imprinted during oocyte differentiation \[as predicted by [@B20]\], the active X is always *maternal* in trophectoderm -- the first tissue to undergo dosage compensation in the mouse embryo. Because X inactivation in the placenta occurs relatively early in mice, it is likely that the paternal X hasn't had time to erase the inactivation imprint imposed during the early stages of spermatogenesis ([@B22]). It remains to be seen if the rodent specific Tsix RNA, which is transcribed only from the maternal X in trophectoderm, protects the active X, regardless of its parental origin, from silencing by *Xist* in other mouse embryonic tissues.

With respect to human cells, we have learned that (1) human oocytes do not express *PRC2* (which imprints the mouse oocyte) ([@B11]), (2) the human maternal X is not imprinted ([@B22]), and (3) human *TSIX* is ineffective, having been truncated during human evolution ([@B25]). Therefore, another means of repressing the *XIST* locus on the future *active* human X is needed to protect it from being silenced. Recent studies suggest that to prevent its heterochromatization by *XIST*, the future human *active* X needs to interact with human chromosome 19 ([@B24]). They reveal a previously unsuspected eight MB region on the short arm of human chromosome 19 (19p13.3-13.2), which contains at least one dosage sensitive gene that is likely to play a role in silencing the *XIST* locus on *one* X chromosome in each cell ([@B23]; [@B24]) ([Table 2](#T2){ref-type="table"}). Candidate genes include satellite attachment factors *SAFB* and *SAFB2*, a cluster of zinc finger proteins that surround *DNMT1* and its co-factor *UHRF1*, among many others. Although most of the zinc finger proteins clustered in the relevant region of human chromosome 19 arose after the split between rodents and humans, the other genes in this region can be found on mouse chromosomes 8, 9, and 17 -- orthologous to human chromosome 19 ([Table 2](#T2){ref-type="table"} and [Figure 1B](#F1){ref-type="fig"}). Again, perhaps human 19 evolved to facilitate the interaction of genes that protect the future active X.

###### 

Location of mouse and human genes that may maintain the active X.

  **Human GENE**   **Human CHROMOSOME**   **5' location of Human Gene *(GRCh38)***   **Mouse GENE**   **5' location of Mouse Gene *(GRCm38)***   **Citation**
  ---------------- ---------------------- ------------------------------------------ ---------------- ------------------------------------------ --------------
  UHRF1            19p13.3                ***19:4,903,079***                         Uhrf1            ***17:56, 303,367***                       [@B24]
  SAFB             19p13.3                ***19:5,623,034***                         Safb             ***17:56, 584,830***                       
  SAFB2            19p13.3                ***19: 5,586,992***                        Safb2            ***17:56, 560,965***                       
  DNMT1            19p13.2                ***19:10,133,343***                        Dnmt1            ***9:20,907,209***                         
  HNRNPM           19p13.2                ***19:8,444,574***                         Hnrnpm           ***17:33, 646,233***                       
  MBD3             19p13.3                ***19:1,576,670***                         Mbd3             ***10:80,392,539***                        
  MBD3L-5L         19p13.2                ***19:8,842,392***                         Mbd3l            ***9:18,478, 359***                        
  PRMT4 or CARM1   19p13.2                ***19:10,871,576***                        Carm1            ***9:21,546,894***                         
  ZNF358           19p13.2                ***19:7,580,178***                         Zfp358           ***8:3,493,138***                          
  ZNF699           19p13.2                ***19:9,291,139***                         *Not found*                                                 
  ZNF627           19p13.2                ***19:11,575,254***                        Znf 867          11:59,461,197                              
  ZNF823           19p13.2                ***19:11,832,080***                        *Not found*                                                 
  ZNF69            19p13.2                ***19:11,887,772***                        *Not found*                                                 
  ZNF44            19p13.2                ***19:12,224,685***                        *Not found*                                                 
  ZNF443           19p13.2                ***19:12,540,521***                        Znf 709          ***8:71,882,068***                         

Bold italics: Human chromosome 19 or mouse orthologs of human chromosome 19.

In the genomics era, many human geneticists tend not to specify which particular autosome encodes genes of interest; therefore, I was surprised to see that many of the proteins that interact with *XIST* to silence the X are encoded by human chromosome 1 ([@B24]) ([Table 1](#T1){ref-type="table"} and [Figure 1A](#F1){ref-type="fig"}), and in the mouse, by the three orthologs of chromosome 1 (chromosomes 1, 3, and 4) ([Table 1](#T1){ref-type="table"}). In mice, these genes are bound to *Xist* at the same developmental stage ([@B21]). To my knowledge, no one has examined the *Xist*-autosomal interactions by RNA FISH to determine if there is clustering of the three murine chromosome 1 orthologs. The positions of these genes on human chromosome 1 is of interest as some of the genes are present on opposing ends of the chromosome, which would require a large fold in the chromosome to facilitate any interaction ([Figure 1A](#F1){ref-type="fig"}). Such intermingling and folding are frequently observed in the 3D nuclear space ([@B17]).

[Table 3](#T3){ref-type="table"} presents conservation data obtained from the UCSC Genome Browser; it shows that of four relevant genes on chromosome 1 that aid *Xist* in silencing the inactive X, only SAFA and LBR have been on the chromosome since we evolved from marsupials. SPEN and RBM15 although on the same chromosome as SAFA and LBR in primates, are on other chromosomes in marmosets and non-primate mammals. In contrast, except in rodents (rat, mouse, and rabbit), the region on chromosome 19 that protects the active X is preserved in primates such as gorilla, orangutang, and marmoset, and other mammals such as cat, dog, pig, horse, cow, and opposum ([Table 4](#T4){ref-type="table"}). The exceptional genes that have left the group include the long noncoding RNA, TINCR, and the MD3L3-5, methyl CPG binding domain proteins, which are on chromosome 19 in primates and in marmoset but are not found in all mammals. The conserved cluster in pig, horse and cow is in the reverse orientation ([Table 4](#T4){ref-type="table"}). These differences interrupt what would otherwise be an exceptionally long synteny block, but the preservation of so many genes in this region, in spite of multiple evolutionary structural alterations, suggests that the local landscape may be important to function. That the chromosome 19 genes in rodents are not conserved as a group argues that their process of ensuring that one X will remain active differs from that of other mammals ([@B34]), perhaps because only rodents have *Tsix* to protect the active X from silencing by *Xist.*

###### 

Conservation of some candidate genes, and not others in various mammals.

  **MAMMAL**   **GENE**   **CHROM**   **5′ LOCATION (nucleotides)**   **GENE**   **CHROM**   **5′ LOCATION (nucleotides)**
  ------------ ---------- ----------- ------------------------------- ---------- ----------- -------------------------------
  HUMAN        DNMT1      **19^∗^**   10,133,346                      SPEN       **1**       15,847,864
               UHRF1      **19**      4,910,367                       LBR        **1**       225,401,503
               SAFB       **19**      5,623,099                       SAFA       **1**       244,850,297
               SAFB2      **19**      5,586,999                       RBM15      **1**       110,286,375
  GORILLA      DNMT1      **19**      9,911,947                       SPEN       **1**       15, 818,157
               UHRF1      **19**      4,549,324                       LBR        **1**       205,129,423
               SAFB       **19**      5,391,167                       SAFA       **1**       224,804,897
               SAFB2      **19**      5,343,115                       RBM15      **1**       111,770,116
  ORANGUTAN    DNMT1      **19**      10,128,395                      SPEN       **1**       212,361,620
               UHRF1      **19**      4,819,523                       LBR        **1**       24,182,913
               SAFB       **19**      5,532,720                       SAFA       **1**       4,279,561
               SAFB2      **19**      5,496,867                       RBM15      **1**       116,356,665
  MARMOSET     DNMT1      **22**      9,536,311                       SPEN       7           50,174,237
               UHRF1      **22**      4,640,990                       LBR        **19**      18,374,272
               SAFB       **22**      5,347,272                       SAFA       **19**      35,988,006
               SAFB2      **22**      5,310,815                       RBM15      7           146,230,306
  Pig          DNMT1      **2**       68,982,341                      SPEN       6           75,015,891
               UHRF1      **2**       73,898,195                      LBR        **10**      13,389,915
               SAFB       **2**       73,300,630                      SAFA       **10**      17,485,493
               SAFB2      **2**       73,334,753                      RBM15      4           109,778,998
  COW          DNMT1      **7**       15,914,205                      SPEN       **16**      52,882,374
               UHRF1      **7**       20,436,673                      LBR        **16**      29,148,981
               SAFB       **7**       19,846,024                      SAFA       **16**      33,162,888
               SAFB2      **7**       19,908,323                      RBM15      3           33,196,547
  SHEEP        DNMT1      **5**       12,315,683                      SPEN       **12**      49,635,296
               UHRF1      **5**       16,747,203                      LBR        **12**      26,512,015
               SAFB       **5**       16,167,299                      SAFA       **12**      30,479,650
               SAFB2      **5**       16,230,105                      RBM15      1           86,670,575
  HORSE        DNMT1      **7**       49,751,153                      SPEN       2           37,048,480
               UHRF1      **7**       3,014,835                       LBR        **30**      8,017,554
               SAFB       **7**       3,409,307                       SAFA       **30**      0,184,656
               SAFB2      **7**       3,388,372                       RBM15      5           57,896,671
  DOG          DNMT1      **20**      50,880,023                      SPEN       2           81,683,829
               UHRF1      **20**      54,858,675                      LBR        **7**       39,291,511
               SAFB       **20**      54,381,519                      SAFA       **7**       35,833,232
               SAFB2      **20**      54,381,353                      RBM15      6           41,645,939
  CAT          DNMT1      **A2**      7,689,975                       SPEN       1           11,528,828
               UHRF1      **A2**      3,678,067                       LBR        **F1**      1,574,749
               SAFB       **A2**      4,176,193                       SAFA       **F1**      5,103,486
               SAFB2      **A2**      4,143,427                       RBM15      1           94,297,141
  OPPOSUM      DNMT1      **3**       431,238,772                     SPEN       4           375,579,105
               UHRF1      **3**       441,797,772                     LBR        **2**       137,055,167
               SAFB       **3**       443,046,263                     SAFA       **2**       142,860,792
               SAFB2      **3**       443,045,746                     RBM15      **2**       479,908,213

∗

Chromosome numbers in bold indicate conservation.

###### 

Site of genes on human chromosome 19 in other mammals.

  **MAMMAL**   **GENE**   **CHROMOSOME**   **SITE 5' (nucleotide)**
  ------------ ---------- ---------------- --------------------------
  HUMAN        SIRT6      19               4,174,109
               PLIN3      19               4,852,208
               UHRF1      19               4,910,367
               KDM4B      19               4,969,121
               TINCR      19               5,560,774
               RFX2       19               5,993,164
               VAV1       19               6,772,726
               MBD3L4     19               7,037,748
               INSR       19               7,112,226
               ZNF358     19               7,516,118
               MAP2K7     19               7,903,891
               FBN3       19               8,130,286
               HNRNPM     19               8,269,278
               ZNF558     19               8,806,170
               OLFM2      19               9,853,718
               DNMT1      19               10,133,346
               DNM2       19               10,828,755
               CARM1      19               10,871,513
  ORANGUTAN    SIRT6      19               4,083,376
               PLIN3      19               4,752,733
               UHRF1      19               4,819,523
               KDM4B      19               4,940,648
               TINCR      19               5,468,562
               RFX2       19               5,907,338
               VAV1       19               6,738,253
               MBD3L4     19               7,005,357
               INSR       19               7,065,165
               ZNF358     19               7,328,128
               MAP2K7     19               7,862,957
               FBN3       19               8,037,199
               HNRNPM     19               8,412,645
               ZNF558     19               8,801,446
               OLFM2      19               9,841,684
               DNMT1      19               10,128,395
               DNM2       19               10,719,521
               CARM1      19               10,872,517
  MARMOSET     SIRT6      22               3,843,381
               PLIN3      22               4,576,676
               UHRF1      22               4,640,990
               KDM4B      22               4,753,547
               TINCR      22               5,280,800
               RFX2       22               5,714,269
               VAV1       22               6,482,055
               MBD3L4     22               6,745,638
               INSR       22               6,884,705
               ZNF358     22               7,258,135
               MAP2K7     22               7,564,197
               FBN3       22               7,702,224
               HNRNPM     22               8,116,508
               ZNF558     22               8,418,995
               OLFM2      22               9,242,165
               DMNT1      22               9,536,311
               DNM2       22               10,141,800
               CARM1      22               10,298,967
  PIG          SIRT6      2                74,568,548
               PLIN3      2                73,970,200
               UHRF1      2                73,898,195
               KDM4B      2                73,747,610
               RFX2       2                72,949,979
               *TINCR*    *not found*      
               VAV1       2                72,327,498
               MBD3L4     2                72,012,690
               INSR       2                71,797,542
               ZNF358                      71,615,476
               MAP2K7     2                71,298,318
               FBN3       2                71,104,118
               HNRNPM     2                70,813,749
               ZNF558     2                70,582,106
               OLFM2      2                68,734,136
               DMNT1      2                68,982,341
               DNM2       2                69,474,069
               CARM1      2                69,602,214
  HORSE        SIRT6      7                2,539,099
               PLIN3      7                2,972,664
               UHRF1      7                3,014,835
               KDM4B      7                3,087,218
               RFX2       7                3,649,694
               *TINCR*    *not found*      
               VAV1       7                4,329,609
               *MBD3L4*   *7*              *52,446,746*
               INSR       7                4,882,687
               ZNF358     7                4,701,725
               MAP2K7     7                5,229,948
               FBN3       7                5,361,278
               HNRNPM     7                52,895,099
               *ZNF558*   *7*              *52,539,233*
               OLFM2      7                49,967,570
               DMNT1      7                49,751,153
               DNM2       7                49,316,987
               CARM1      7                49,257,318
  COW          SIRT6      7                21,079,141
               PLIN3      7                20,507,000
               UHRF1      7                20,436,673
               KDM4B      7                20,308,693
               RFX2       7                19,126,799
               *TINCR*    *not found*      
               VAV1       7                18,866,379
               MD3L4      7                17,264,390
               INSR       7                17,276,143
               ZNF358     7                17,610,070
               MAP2K7     7                17,891,887
               FBN3       7                18,005,675
               HNRNPM     7                18,289,395
               ZNF558     7                17,220,537
               OLFM2      7                15,550,353
               DNMT1      7                15,914,205
               DNM2       7                16,465,942
               CARM1      7                16,571,428
  DOG          SIRT6      20               55,416,563
               PLIN3      20               54,924,119
               UHRF1      20               54,858,675
               KDM4B      20               54,715,308
               RFX2       20               54,013,618
               *TINCR*    *not found*      
               VAV1       20               53,482,255
               MBD3L4     20               53,213,540
               INSR       20               52,017,347
               ZNF358     20               52,314,421
               MAP2K7     20               52,594,536
               FBN3       20               52,723,997
               HNRNPM     20               52,997,963
               ZNF558     20               51,897,297
               OLFM2      20               51,148,154
               DMNT1      20               50,880,023
               DNM2       20               50,399,784
               CARM1      20               50,331,081
  CAT          SIRT6      A2               3,162,759
               PLIN3      A2               3,631,793
               UHRF1      A2               3,678,067
               KDM4B      A2               3,765,143
               RFX2       A2               4,427,650
               *TINCR*    *not found*      
               VAV1       A2               5,108,402
               *MBD3L4*   A2               5,395,765
               INSR       A2               6,443,171
               ZNF358     A2               6,267,306
               MAP2K7     A2               6,004,415
               FBN3       A2               5,820,368
               HNRNPM     A2               5,569,560
               ZNF558     A2               6,657,696
               OLFM2      A2               7,484,626
               DMNT1      A2               7,689,975
               DNM2       A2               8,118,334
               CARM1      A2               8,257,736
  OPOSSUM      SIRT6      3                440,652,009
               PLIN3      3                441,702,797
               UHRF1      3                441,797,772
               KDM4B      3                441,910.670
               RFX2       3                443,674,276
               *TINCR*    *not found*      
               VAV1       3                444,980,624
               *MBD3L4*   *not found*      
               INSR       3                463,520,164
               ZNF358     *not found*      
               MAP2K7     3                462,757,443
               FBN3       3                461,508,720
               HNRNPM     3                460,359,655
               *ZNF558*   4                *409,014310*
               OLFM2      3                431,554,923
               DMNT1      3                431,238,772
               DNM2       3                430,280,994
               CARM1      3                430,212,862
  MOUSE        SIRT6      10               81,621,787
               PLIN3      17               56,277,475
               UHRF1      17               56,304.407
               KDM4B      17               56,326,074
               RFX2       17               56,775,897
               *TINCR*    *not found*      
               VAV1       17               57,279,100
               *MBD3L4*   *not found*      
               INSR       8                3,150,922
               ZNF358     8                3,493,154
               MAP2K7     8                4,238,740
               FBN3       18               58,012,265
               HNRNPM     17               33,646,236
               *ZNF558*   *not found*      
               OLFM2      9                20,672,332
               DNMT1      9                20,907,209
               DNM2       9                21,425,244
               CARM1      9                21,546,894
  RAT          SIRT6      7                10,937,622
               PLIN3      9                10,774,869
               UHFR1      9                10,738,211
               KDM4B      9                10,656,035
               RFX2       9                10,216,249
               *TINCR*    9                10,499,290
               VAV1       9                9,617,783
               *MBD3L4*   *8*              *18,226,238*
               INSR       12               1,678,623
               ZNF358     12               2,046,542
               MAP2K7     12               2,546,139
               FBN3       18               53,070,463
               HNRNPM     7                18,516,253
               *ZNF558*   *not found*      
               OLFM2      8                21,684,494
               DNMT1      8                21,922,515
               DNM2       8                22,458,869
               CARM1      8                22,527,213
  RABBIT       SIRT6      3                16,044,566
               PLIN3      *not found*      
               UHRF1      1                47,672,908
               KDM4B      1                47,085,460
               RFX2       1                51,045,589
               *TINCR*    *not found*      
               VAV1       13               56,144,807
               *MBD3L4*   *unknown*        
               INSR       un0069           1,077,773
               ZNF358     un0069           914,737
               MAP2K7     un0069           665,019
               FBN3       3 un0069         11,898,428 502,497
               HNRNPM     un0069           252,960
               ZNF558     *not found*      
               OLFM2      un0135           324,580
               DNMT1      un0135           156,550
               DNM2       13               20,368,794
               CARM1      1                51,421,465

Most likely, the relevant genes on the same chromosome are co-regulated. The advantage of genes clustered in interphase is that they can be programmed for simultaneous transcription. To silence *XIST* on the future active X, some genes in the chromosome 19 cluster might be transcribed together, perhaps if they are close enough in 3D space, as a single transcript. The telomeric location of genes on primate chromosome 1 that participate in *XIST* silencing ([Figure 1A](#F1){ref-type="fig"}) suggest that the two ends of the chromosome might physically interact at the time of transcription.

Several important questions remain unanswered: First, how do multiple genes in the inactivation pathway on human chromosome 1 (or in the activation pathway on chromosome 19) coordinately interact with each other? And then, how do autosomal genes encoding protein products, interact with the X chromosome?

Recent studies suggest that the intra-chromosomal gene interactions occur within the same topologically-associating-domain (TAD) ([@B29]; [@B8]) and that TADS align with co-coordinately regulated gene clusters, fostering long-range contacts and preventing deleterious interactions between genes in different TADs ([@B8]) One would like to examine the candidate genes on human chromosomes 1 and 19, at the appropriate time in development, to determine if they are located within the same TAD, or are otherwise coordinately regulated. It is unlikely that the occurrence of multiple silencers of the inactive X on human chromosome 1 and *XIST* repressors on human chromosome 19 is coincidental.

The question of how genes on an autosome interact with the genes on the X chromosome is especially challenging because in the human species either one or several X chromosomes can be silenced within a cell, the number dependent upon the number of X chromosomes in the genome. All but one X chromosome are silenced no matter how many are in the cell, nor the sex of the individual ([@B10]). Therefore, only one X chromosome *resists* silencing no matter the number of X chromosomes in the cell.

Clearly, suppressing the *XIST* locus on the future active X is easier for males than females. We know this because of the specific loss of females who reduplicate the essential chromosome 19 gene(s), presumably because reduplication enables both X's to be active -- a known lethal event in diploid cells. At least five percent more pre-implantation human females are miscarried than are males ([@B24]). If males reduplicate the *XIST* repressor, it has little consequence, but females who by chance inactivate both *XIST* loci, die before they implant into the uterus. This suggests that not only when this region of chromosome 19 is duplicated, but even, when the chromosome is normal, the required interaction is a difficult one, as either too little or too much *XIST* repressor would lead to a lethal event (too many active X's or no active X). The former does not occur as often in males who have only one X chromosome: too much repressor is not lethal, although too little might be.

And there is the question of gene dosage. How in a diploid cell do two autosomes cooperate to make an inhibitor for a single X chromosome? In the case of more than two X chromosomes, how is the right dosage of gene product from chromosome 1 achieved? On one hand [@B18] and more recently [@B28] suggest that the two autosomes might pair to synthesize a single product. One such product might be a dimeric protein, there is also the possibility of competitive inhibition. Once, a molecule of gene product arrives on one X chromosome then the other(s) are unable to be hit. On the other hand, perhaps, not all attempts to activate or inactivate the chromosome are successful, and so the process is stochastic. That many errors occur while repressing *XIST* on the future active X might explain a significant loss of pre-implantation females, even in absence of gene reduplication.

To answer these questions one needs to identify genome interactions during the pre-implantation development of the human embryo, at the time of X inactivation. One can use chromosome capture such as Hi-C, 3D RNA-FISH ([@B35]) (to see if nascent transcripts are transcribed together). Single-cell RNA-Seq as has been recently described in the mouse ([@B5]), examining the candidate genes. The best human model would be the beginning of cleavage to embryonic day 10. The inability to study available human embryos is a decided disadvantage for American investigators, but I hope that my colleagues in other countries will carry out such studies. For the human X: 19 interaction, embryonic day 4--7 would probably be appropriate, whereas human embryonic day 6--9 should capture the chromosome 1: X interaction.
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